Venture capital funds based in China poured US$1.4 billion into private US biotechnology firms in the three months ending March 31, accounting for about 40 per cent of the US$3.7 billion that the companies raised in the period overall, according to data provider PitchBook.
{iframe}http://www.scmp.com/business/global-economy/article/2142351/chinese-funds-pour-us14b-us-biotechnology-firms-first-three{/iframe}